Navigation Links
Caloric Restriction in Non-obese People Extends Life Span

Caloric Restriction in non-obese people too is not without benefits. Caloric Restriction causes less oxidative damage in muscle cells which delays// aging and extends life span.

This new study was conducted by Anthony Civitarese, Eric Ravussin, and colleagues (Pennington Biomedical Research Center).Oxidative damage has been linked to aging, and this could explain how limiting calorie intake without malnutrition extends life span.

A calorie-restricted diet provides all the nutrients necessary for a healthy life but minimizes the energy (calories) supplied in the diet. This type of diet increases the life span of mice and delays the onset of age-related chronic diseases such as cancers, heart disease, and stroke in rodents. There are also hints that people who eat a calorie-restricted diet might live longer than those who overeat. In addition, calorie-restricted diets beneficially affect several biomarkers of aging, including decreased insulin sensitivity (a precursor to diabetes).

But how might caloric restriction slow aging? A major factor in the age-related decline of bodily functions is the accumulation of "oxidative damage" in the body's proteins, fats, and DNA. Oxidants—in particular, chemicals called "free radicals"—are produced when food is converted to energy by cellular structures called mitochondria. One theory for h ow caloric restriction slows aging is that it lowers free-radical production by inducing the formation of efficient mitochondria.

Civitarese and colleagues enrolled 36 healthy overweight but non-obese young people into their study. A third of them received 100% of their energy requirements in their diet; the caloric restriction (CR) group had their calorie intake reduced by 25%; and the caloric restriction plus exercise (CREX) group had their calorie intake reduced by 12.5% and their energy expenditure increased by 12.5%.

The researchers found that a 25% caloric deficit for 6 months, a
'"/>




Page: 1 2

Related medicine news :

1. Progression Of ALS May Be Prevented By A High Caloric Diet
2. FDA Imposes New Restrictions On Roches Accutane
3. Drink till you drop dead in English Pubs- Restriction on Timings Lifted
4. Bird Flu Restrictions To Be Lifted In Scotland
5. Restriction of Carbohydrates to Prevent Alzheimers Disease
6. No More Dietary Restriction for Heartburn Patients - Study Says
7. Liberated British Mothers Want No Restriction on Breast Feeding In Public
8. Restrictions Imposed on Sale of Edible Common Salt
9. Bush Supports Restriction to ‘Morning–After’ Pll
10. Calorie Restriction May Prevent, Reduce Alzheimer’s Neuropatholog
11. Gene Responsible for Ageing Process Discovered – and Calorie Restriction Could Hel
Post Your Comments:
(Date:5/15/2008)...-869 to be Promising in Targeting Cancer Cells, ...TT PARK, Ill., May 15 /PRNewswire-FirstCall/ -- Ab... trial data of several investigative,compounds in ...rican,Society of Clinical Oncology (ASCO) Annual M...ntations include ABT-263, a Bcl-2 family protein,a...
(Date:5/15/2008)...inhua-PRNewswire-FirstCall/ -- China Yingxia,Inter...Yingxia" or "the,Company"), a leading provider in ...ent, manufacture and distribution of organic nutri...re products in the People,s Republic,of China ("PR...first,quarter ended March 31, 2008., First Quar...
(Date:5/15/2008)... goal of tailoring cancer treatment for each indiv...l Center today presented a study suggesting a simp...s treatment efficacy for patients with metastatic ...ometimes months to determine if a particular cance...ng to observe any significant radiographic changes...
(Date:5/15/2008)...n called IGF-1R in patients with gastrointestinal ...ient would be less responsive to the drug imatinib...K. Godwin, Ph.D., a researcher at the Fox Chase Ca...have shown that GIST cells, especially Gleevec-res...lopment for treatment-resistant breast cancer, a f...
Breaking Medicine News(10 mins):Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 2Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 3Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 4Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 5Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 6Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 2Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 3Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 4Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 5Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 6Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 7Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 8Health News:China Yingxia International, Inc. Reports First Quarter 2008 Results 9Health News:Study suggests blood test can help improve treatment outcomes for breast cancer patients 2Health News:Protein predicts Gleevec resistance in gastrointestinal tumors 2
...cipate seizures in children with epilepsy.The most...udy was // licking, often of the face, followed b...ctive" behavior without aggression. In previous st...that licking may abort or even prevent their seizu...
...feeling sick and with a number of other side effec...tment // and all they go through with it may not e...ng a new, more targeted approach to delivering che... aggressive way available to deliver chemotherapy ...
...icles and cause prostate cancer cells to grow. Low...shrink or grow more slowly. However, hormone thera... other treatments such as surgery or radiation are...common treatment for prostate cancer significantly...
...atment proves to be the best option to substantial...gery to remove part of the affected vein in additi...new treatment option for leg ulcers .Surgery did n...ms of venous ulcer healing, but recurrence rates w...
Other Medicine News:
(Date:5/15/2008)...trated in Blacks, Hispanics/Latinos, People ...ARSIPPANY, N.J., May 15 /- Daiichi Sa... the American Society of,Hypertension,s Twenty- Th...leans demonstrated that the powerful combination d... safely and effectively helped,patients across sev...
(Date:5/15/2008)...15 /- Ergonex Pharma today,announced ...n (FDA) has,granted orphan drug designation to Ter...ertension (PAH). Terguride is currently being eval...e., "The FDA,s grant of orphan drug designation t... development program by offering regulatory,clini...
(Date:5/15/2008)... for an Antiplatelet Therapy that, Combined, with ... of Plavix/Iscover and Aspirin, According to a...s., May 15 /- Decision Resources, one...s for pharmaceutical and,healthcare issues, finds ...rovement in patient compared to Sanofi-Aventis/Bri...
(Date:5/15/2008)...Annual Meeting of The American Society of ..., IRVINE, Calif., May 15 /...today announced the presentation of updated data,f...murtide (L-MTP-PE) in,patients with lung metastase...a rare and often fatal bone tumor that typically a...
Breaking Medicine Technology:Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution 1599 1Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution 1599 2Personalized Medicine The Genomic Revolution in Cardiac Care 330 1Personalized Medicine The Genomic Revolution in Cardiac Care 330 2Personalized Medicine The Genomic Revolution in Cardiac Care 330 3Alba Therapeutics Announces Phase IIb Clinical Trial for Oral AT 1001 for the Treatment of Celiac Disease 326 1Alba Therapeutics Announces Phase IIb Clinical Trial for Oral AT 1001 for the Treatment of Celiac Disease 326 2Early Human Like Skeletons Are First Outside of Africa 1595 1Early Human Like Skeletons Are First Outside of Africa 1595 2Early Human Like Skeletons Are First Outside of Africa 1595 3
...tection Observed Prior to or Up to 24 Hours After,...7 /PRNewswire/ -- Targanta,Therapeutics Corporatio...demonstrating oritavancin as a potential therapy f...cterium which causes anthrax,an acute infectious ...glycopeptide antibiotic for the treatment of serio...
...-(BUSINESS WIRE)--May 25, 2007 - GTx, Inc., (NASDA... Phase II proof of,concept clinical trial of Ostar...ial evaluating ACAPODENE(R) (toremifene citrate) 8... androgen,deprivation therapy (ADT) will be presen...rican Society of Clinical Oncology being,held June...
Other Medicine Technology:Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 2Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 3Targanta Study Shows Oritavancin Treatment Effective in a Mouse,Model of Anthrax 4GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 2GTx Announces Presentation of Ostarine and Acapodene Data at 2007,ASCO Annual Meeting 3
A Western Blot Immunassay for the detection of antibodies to primarily anti-myelin associated glycoproteins (anti-MAG) and other glycolipid autoantibodies in human serum.
Triturus® is an open and completely automated ELISA immunoassay analyzer which can perform a variety of different tests on a series of samples and process several batches simultaneously.
...nesthesia and Respiratory Products, ,Westmed desi...ical devices for Anesthesia and Respiratory profes...products that enhance the clinician's ability to d...ention to the bottom line. , ,Our web site is des...
...he age of 3 can choose either the PARI LC PLUS®...applies to both:, ,Maximize aerosol output when t...n the patient exhales using two one-way valves. Ba... nebulizer. The result is a high percentage of par...
Medicine Products: